Answers are grounded in this paper and cite their sources.
Studies of the biosynthesis of aminocyclitol antibiotics, especially neomYcin, have led to development of the mutasynthetic technique for the preparation of related antibiotics.A specific type of mutant strain of the microorganism which normally produces the aminocyclitol antibiotic is first prepared.The mutant sought is one unable to produce the aminocyclitol subunit and thus it can produce the normal antibiotic only in the presence of added native aminocyclitol.Alternatively, it can produce related (mutasynthetic) antibiotics in the presence of other aminocyclitols (mutasynthons).Mutasynthesis is not limited to aminocyclitol antibiotics but it has now been used to produce compounds related to essentially all of the clinically useful aminocyclitol antibiotics.Not all potential mutasynthons are accepted by the mutants and some accepted lead to antibiotics more widely altered than by the simple substitution of a natural by an unnatural aminocyclitol.Thus, mutasynthesis has considerable potential in the study of the structural requirements for bioactivity as well as in the design of new antibiotics.The search for new antibiotics follows many trails {1,2).The classical biological approach is that of screening, in which a soil sample is examined for the microorganisms which produce antibiotics.Although somewhat random, this method has led historically to some of the greatest successes in chemotherapy through the discovery of tetracycline, cephalosporin, chloramphenicol and erythromYcin, to name but a few.As Screening has become more expensive and the probability of finding a new antibiotic statistically less attractive, newer approaches to the development of antibiotics have been investigated.A number of these newer procedures are at least partially chemical in nature.Total synthesis has only rarely provided useful new antibiotics due to the complexity of the .structuresinvolved, with their many asymmetric centers.However, partial synthesis has provided us with the semisynthetic penicillins and other useful chemotherapeutic agents (3), while chemical modification of older antibiotics, such as the conversion of rifamYcin B to rifampicin (4) and that of lincomycin to clindamycin (5), has also proved successful.What I shall discuss here is a different approach to the preparation of new antibiotics, a procedure for which we have coined the term mutasynthesis.
No takes yet. Share an insight, caveat, or question.
K. L. Rinehart (1977) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: